ArticleBMC infectious diseases2025
Risk factors associated with Cryptosporidium species and genotypes in Tennessee, 2018-2023.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCryptosporidiosis is a leading cause of zoonotic illness. We aimed to describe cryptosporidiosis illnesses in Tennessee by species and molecular subtypes, and explore epidemiological risk factors.
methodsCryptosporidium is a reportable condition in Tennessee. Cases are investigated and molecular subtyping is performed. Collected data includes patient demographics, risk factors, laboratory results, and Cryptosporidium species and subtype. We described Tennessee residents with cryptosporidiosis during 2018-2023. To explore risk factors, we used binomial probabilities to compare exposure frequencies with the Foodborne Diseases Active Surveillance Network (FoodNet) Population Survey.
resultsDuring 2018-2023, Tennessee recorded 1174 cryptosporidiosis cases. Of those, 282 (24%) had species information and 214 (18%) had genotype information. Of 802 laboratory-confirmed cases without species information, 664 (83%) did not have a specimen submitted for molecular subtyping. Most frequently identified species were C. parvum (n = 183, 65%) and C. hominis (n = 60, 21%) with most frequently identified subtypes being C. parvum subtypes IIaA15G2R1 (n = 80) and IIaA15G2R2 (n = 15), and C. hominis subtype IfA12G1R5 (n = 15). C. felis (n = 8), C. ubiquitum (n = 5), C. meleagridis (n = 3), C. canis (n = 2), and C. deer mouse subtypes (n = 2) were also identified. Rates were higher for C. parvum in rural counties and C. hominis in urban counties. Persons with C. parvum infections more often reported contact with goats, cows, or sheep compared to the population (39% vs. 6%, P <.001). Persons with C. hominis infections more often reported contact with natural (22% vs. 9%, P =.003) and treated (32% vs. 12%, P <.001) water, and having contact with another person with diarrheal illness (28% vs. 15%, P =.013).
conclusionsMolecular cryptosporidiosis surveillance can facilitate more detailed understanding of cryptosporidiosis risk factors and prevention measures. To best use this tool, a greater proportion of specimens need to be submitted for molecular subtyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.